Skip to main content
Vyome Holdings, Inc logo

Vyome Holdings, Inc — Investor Relations & Filings

Ticker · HIND ISIN · US67424L2097 US Manufacturing
Open in API
Filings indexed 590 across all filing types
Latest filing 2023-02-15 Major Shareholding Noti…
Country US United States of America
Listing US HIND

About Vyome Holdings, Inc

https://www.reshapelifesciences.com/oba…

Vyome Holdings, Inc. is a clinical-stage biotechnology company focused on developing a portfolio of assets for immuno-inflammatory and potential orphan diseases. The company utilizes an artificial intelligence (AI)-driven platform to accelerate its research and development pipeline. Its operations are structured to leverage innovation and R&D capabilities across both the United States and India.

Recent filings

Filing Released Lang Actions
SC 13D Filing
Major Shareholding Notification
2023-02-15 English
SC 13G/A Filing
Major Shareholding Notification
2023-02-14 English
8-K Filing
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated February 6, 2023, by ReShape Lifesciences Inc. It details the entry into a material definitive agreement related to a firm commitment public offering of units consisting of common stock and warrants. The document includes specifics about the underwriting agreement, the offering price, the number of units, and the use of proceeds. It also references the registration statement on Form S-1 and includes exhibits such as the underwriting agreement and press releases announcing the pricing and closing of the offering. The content focuses on the company's capital raising activities and financing arrangements. Given these details, the document is best classified as a Capital/Financing Update (CAP). The document length (9255 characters) and detailed content confirm it is not merely an announcement but a substantive filing about financing activity.
2023-02-10 English
424B4 Filing
Capital/Financing Update Classification · 100% confidence The document is a detailed prospectus for a public offering of units consisting of common stock and warrants. It includes extensive information about the offering terms, underwriting, risk factors, management discussion, and financial statements. The presence of a registration number, offering price, underwriting details, and a comprehensive table of contents typical of a securities offering document indicates this is a capital raising filing. The document is not an earnings release, annual report, or management discussion alone, but a formal offering prospectus related to financing activities. Therefore, it fits the category of Capital/Financing Update (CAP). The document length and detail confirm it is the full prospectus, not just an announcement or summary.
2023-02-08 English
S-1/A Filing
Regulatory Filings Classification · 95% confidence The document is a Form S-1 Registration Statement Amendment No. 3 filed with the U.S. Securities and Exchange Commission by ReShape Lifesciences Inc. It is a registration statement for an offering of securities, including shares of common stock and warrants. The text includes detailed information typical of a prospectus, such as risk factors, use of proceeds, capitalization, dilution, management discussion and analysis, business description, executive compensation, and legal matters. It is not a financial report like an annual or quarterly report, nor is it an earnings release or a call transcript. It is also not a proxy statement or voting results announcement. The document is a regulatory filing related to securities registration and offering under the Securities Act of 1933. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length is substantial (15,000 characters), and it contains detailed regulatory disclosure information, not just an announcement or certification, so it is not RPA or a certification filing.
2023-02-03 English
S-1/A Filing
Capital/Financing Update Classification · 100% confidence The document is titled 'Amendment No. 2 to FORM S-1 Registration Statement under the Securities Act of 1933' filed with the SEC. It includes detailed exhibits, legal opinions, and amendments related to a registration statement for securities offering. The Form S-1 is a registration statement used for initial public offerings or other securities offerings, which falls under capital raising activities. The document is not an annual or quarterly report, earnings release, or management discussion. It is a regulatory filing related to capital markets and securities registration. Given the nature of the document as an amendment to a registration statement for securities issuance, the appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is the filing itself, not just an announcement or certification, so it is not RPA or RNS.
2023-02-02 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.